MariMed Focusing on Continuing Growth Momentum With New Facilities and Products as Marijuana Legalization Spreads
LOS ANGELES, CA and NEWTON, MA / ACCESSWIRE / June 1, 2018 / MariMed Inc. (OTCQB: MRMD) will be presenting at the LD Micro Invitational on Monday, June 4, at 4:30 PM PST / 7:30 PM EST. Mr. Robert Fireman, CEO of MariMed Inc., will be highlighting MariMed's 3 years of year-over-year quarterly growth as a result of developing and operating some of the nation's most acclaimed state-licensed cannabis cultivation, production, and dispensing facilities in multiple states. He will share progress on the continued growth of the company's business across the country, the 2018 launch of business in its facilities in Massachusetts and Maryland, and the expansion of its Kalm Fusion and Betty's Eddies brands, and the launch of its new Nature's Heritage Cannabis brand in Maryland.
To arrange a meeting with MariMed management, please use the MeetMax system.
"We are honored to have MariMed back to present at our 8th annual Invitational Event," said Chris Lahiji, President of LD MICRO. "As Congress considers nearly 40 marijuana legalization bills proposed from both parties, and a bipartisan group of senators is crafting a bill that will formalize individual states' rights to override the federal prohibition on marijuana, we see tremendous growth potential for cannabis companies now and long-term. Perhaps it won't be long before we'll be able to enjoy Nature's Heritage Cannabis samples with wine during our networking sessions."
The conference will be held at the Luxe Sunset Bel-Air Hotel, in Los Angeles, California and will feature more than 200 companies in the small/micro-cap space.
View MariMed's profile here: https://www.ldmicro.com/profile/MRMD.
Search MariMed and post on social media with the hash tag #MedicatedByMarimed:
About MariMed Inc.:
MariMed designs, develops, finances, and optimizes the success of medical cannabis cultivation, production, and dispensary facilities through its validated management. MariMed's team has developed or is in the process of developing state-of-the-art regulatory-compliant facilities in DE, IL, NV, MD, MA, and RI. These facilities are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations. In addition, MariMed is on the forefront of precision dosed branded products for the treatment of specific medical symptoms. MariMed currently distributes its branded products in select states and is expanding licensing and distribution to numerous additional states encompassing thousands of dispensaries. MariMed Inc. is one of the 17 top-performing public cannabis companies in the U.S. tracked on the U.S. Marijuana Index, (www.marijuanaindex.com). For additional information, visit www.MariMedAdvisors.com
Jon Levine, CFO, MariMed
Tyler Troup, Circadian Group
+1 (866) 950 8300
Julie Shepherd, Accentuate PR
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).
In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.
Forward Looking Statements:
This release contains certain forward-looking statements and information relating to MariMed Inc., that is based on the beliefs of MariMed Inc.'s management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company's services and products, changes in the law and its enforcement and changes in the economic environment. Additional risk factors are included in the Company's public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as "hoped," "anticipated," "believed," "planned, "estimated," "preparing," "potential," "expected" or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.
SOURCE: MariMed Inc.